These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7538974)

  • 21. Generation and identification of monoclonal antibodies against FNIII domain D of human tenascin-C.
    Wang YC; Zheng LH; Ma BA; Zhou Y; Fan QY
    Hybridoma (Larchmt); 2010 Feb; 29(1):13-6. PubMed ID: 20199146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer.
    Takeda A; Otani Y; Iseki H; Takeuchi H; Aikawa K; Tabuchi S; Shinozuka N; Saeki T; Okazaki Y; Koyama I
    World J Surg; 2007 Feb; 31(2):388-94. PubMed ID: 17219282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin αVβ3/nuclear factor-κB/interleukin-6 axis.
    Shimojo N; Hashizume R; Kanayama K; Hara M; Suzuki Y; Nishioka T; Hiroe M; Yoshida T; Imanaka-Yoshida K
    Hypertension; 2015 Oct; 66(4):757-66. PubMed ID: 26238448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction.
    Sato A; Aonuma K; Imanaka-Yoshida K; Yoshida T; Isobe M; Kawase D; Kinoshita N; Yazaki Y; Hiroe M
    J Am Coll Cardiol; 2006 Jun; 47(11):2319-25. PubMed ID: 16750702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competition and cooperation between tenascin-R, lecticans and contactin 1 regulate neurite growth and morphology.
    Zacharias U; Rauch U
    J Cell Sci; 2006 Aug; 119(Pt 16):3456-66. PubMed ID: 16899820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
    Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
    Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoforms of cellular fibronectin and tenascin in amniotic fluid.
    Linnala A; von Koskull H; Virtanen I
    FEBS Lett; 1994 Jan; 337(2):167-70. PubMed ID: 7507066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma.
    Sugawara I; Hirakoshi J; Kusakabe M; Masunaga A; Itoyama S; Sakakura T
    Jpn J Cancer Res; 1993 Jul; 84(7):703-7. PubMed ID: 7690353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes.
    Parekh K; Ramachandran S; Cooper J; Bigner D; Patterson A; Mohanakumar T
    Lung Cancer; 2005 Jan; 47(1):17-29. PubMed ID: 15603851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis.
    Hasegawa M; Hirata H; Sudo A; Kato K; Kawase D; Kinoshita N; Yoshida T; Uchida A
    J Rheumatol; 2004 Oct; 31(10):2021-6. PubMed ID: 15468369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum tetranectin in patients with acute pelvic inflammatory disease (PID). Correlation to clinical and laboratory findings.
    Høgdall CK; Christiansen M; Brihmer C
    Acta Obstet Gynecol Scand; 1995 Mar; 74(3):203-7. PubMed ID: 7534970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
    Neidhart M; Müller-Ladner U; Frey W; Bosserhoff AK; Colombani PC; Frey-Rindova P; Hummel KM; Gay RE; Häuselmann H; Gay S
    Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.
    Borsi L; Carnemolla B; Nicolò G; Spina B; Tanara G; Zardi L
    Int J Cancer; 1992 Nov; 52(5):688-92. PubMed ID: 1385335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of extracellular matrix (tenascin) in the gastric cancer--an immunohistochemical study].
    Yano S
    Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1085-91. PubMed ID: 7694065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
    Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
    Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma.
    Katenkamp K; Berndt A; Hindermann W; Wunderlich H; Haas KM; Borsi L; Zardi L; Kosmehl H
    J Pathol; 2004 Jul; 203(3):771-9. PubMed ID: 15221936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermo-epidermal separation is associated with induced tenascin expression in human skin.
    Schenk S; Bruckner-Tuderman L; Chiquet-Ehrismann R
    Br J Dermatol; 1995 Jul; 133(1):13-22. PubMed ID: 7545419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.
    Gebauer F; Gelis S; Zander H; Meyer KF; Wolters-Eisfeld G; Izbicki JR; Bockhorn M; Tachezy M
    Oncotarget; 2016 Apr; 7(15):20945-52. PubMed ID: 26967391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C.
    Chung CY; Erickson HP
    J Cell Biol; 1994 Jul; 126(2):539-48. PubMed ID: 7518469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer.
    Ishiwata T; Takahashi K; Shimanuki Y; Ohashi R; Cui R; Takahashi F; Shimizu K; Miura K; Fukuchi Y
    Anticancer Res; 2005; 25(1B):489-95. PubMed ID: 15816617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.